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Fig. 1. Relationship between mean (± SEM) ratio of postdialysis/predialysis acylcarnitine concentrations and carbon-chain length of the acyl
group.
significant correlation between carbon-chain length and
dialytic removal (Fig. 1).
In light of these findings, we propose that, in combina-
tion with disturbed metabolism, the observed alterations
in the carnitine pool are contributed to by a decrease in
the dialytic removal of acylcarnitines, in particular long-
chain acylcarnitines, most likely a result of the increased
molecular weight and lipophilicity that accompanies in-
creased chain length.
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Albuminuria in patients with
hepatitis C: Is inflammation
the missing link?
To the Editor: The study by Liangpunsakul and Cha-
lasani on the association between hepatitis C and microal-
buminuria reports an independent association between
these 2 clinical entities [1]. The significance of their results
may, however, be limited by the fact that their use of 1
albumin to creatinine ratio to measure microalbuminuria
may be a source of error, including an underestimation
of microalbuminuria in some some racial/ethnic groups
[2].
Futhermore, their failure to find an association be-
tween hepatits C and the metabolic syndrome, may be
explained by the fact that in at least in some age groups,
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microalbuminuria may not be necessarily a component
of the metabolic syndrome [3].
Finally, on the basis of other studies, one may speculate
that chronic inflammation may be the underlying mech-
anism that explains the association of hepatic C with mi-
croalbuminuria because atherosclerosis itself appears to
be an inflammatory disorder [4, 5].
In their study, markers of inflammation such as IL-6
and C-reactive protein were not measured.
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Reply from the Authors
We are very grateful to Dr. Nzerue for his thoughtful
comments on our paper [1]. In this correspondence, we
respond to thoughtful queries by Dr. Nzerue.
First, in our discussion, we admitted that a single mea-
surement of urine albumin to creatinine ratio to assess
for the presence of microalbuminuria is not ideal. Unfor-
tunately, the NHANES III is a cross-sectional study and
sequential urinary data were not available.
Second, Dr. Nzerue points out that there is not a con-
sistent relationship between the metabolic syndrome and
microalbuminuria in some age groups, and this may ex-
plain why we failed to observe an association between
hepatitis C and the metabolic syndrome. While this is
plausible, more rigorous studies are needed to examine
this issue as our results disagree with a previous retrospec-
tive cohort study [2], which showed a high prevalence of
the metabolic syndrome in patients with hepatitis C.
Third, we accept the possibility that chronic inflamma-
tion or immune processes are involved in the pathogen-
esis of microalbuminuria in hepatitis C subjects. We ex-
plored this possibility, but found that cryoglobulin levels
were not measured in the NHANES III, and rheumatoid
factor data were missing in most patients in the hepatitis
C cohort. However, we failed to find any differences in
the levels of C-reactive protein in subjects with hepatitis
C and controls (0.41 ± 0.62 vs. 0.44 ± 0.86 mg/dL, P =
0.5).
Our study should be viewed as exploratory in na-
ture and our observations require validation in ongo-
ing prospective studies (e.g., NIDDK-funded Virahep-C
study).
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Red blood cell deformability
and diabetic nephropathy
To the editor: In an interesting study, Brown et al [1]
found an impaired red blood cell deformability in 57 adult
type 2 diabetic patients. They used a filtration technique
using polycarbonate membranes with straight channels
of 3 micrometer pore diameter. In patients with diabetic
nephropathy they found an increased impairment in red
blood cell deformability. The hypothesis that an impaired
red blood cell deformability contributes to renal function
decline is very attractive and may give rise to therapeutic
possibilities. Many studies found an impaired red blood
cell deformability in diabetic patients; others, however,
did not. Years ago we tested the hypothesis that red blood
cell deformability contributes to diabetic nephropathy us-
ing both ektacytometry and erythrocyte filtration, with
micropores with a diameter of 5 micrometer [2]. In or-
der to imitate local circumstances in the kidney red blood
cell, deformability was also measured in hyperosmolar so-
lutions. Seventy-one insulin-dependent diabetic patients
were included, 25 patients without any sign of organ dam-
age, 21 patients with microalbuminuria, 13 patients with
overt nephropathy, and 12 patients with leg ulceration.
No decreased red blood cell deformability was found in
any of the diabetic groups with either technique, neither
